Publications for Hardeep Kaur hardeep.kaur@tu.edu
Sofiyev, V., Kaur, H., Snyder, B. A., Hogan, P. A., Ptak, R. G., Hwang, P., & Gochin, M. (2017). Enhanced potency of bivalent small molecule gp41 inhibitors, Bioorganic & Medicinal Chemistry, 25(1), 408-420. doi:10.1016/j.bmc.2016.11.010
Chu, S., Kaur, H., Nemati, A., Walsh, J. D., Partida, V., Zhang, S. Q., & Gochin, M. (2015). Swapped-domain constructs of the glycoprotein-41 ectodomain are potent inhibitors of HIV infection. ACS Chemical Biology, 10(5), 1247-1257. doi:10.1021/cb501021j
Kemnade, J. O., Seethammagaria, M., Collinson-Pautza, M., Kaur, H., Spencer, D. M., & McCormick, A. A. (2014). Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo. Vaccine, 32(33), 4228-4233. doi:10.1016/j.vaccine.2014.04.051
Zhou, G., Sofiyev, V., Kaur, H., Snyder, B. A., Mankowski, M. K., Hogan, P. A., . . . Gochin, M. (2014). Structure-activity relationship studies of indole-based compounds as small molecule HIV-1 fusion inhibitors targeting glycoprotein 41. Journal of Medicinal Chemistry, 57(12), 5270–5281. doi:10.1021/jm500344y
Holden, P. M., Kaur, H., Goyal, R., Gochin, M., & Rizzo, R. C. (2012). Footprint-based identification of viral entry inhibitors targeting HIVgp41. Bioorganic and Medicinal Chemistry Letters, 22(8), 3011-3016. doi:10.1016/j.bmcl.2012.02.017
